Author details

Full Name

Lavinia P Middleton

Affiliation

The University of Texas MD Anderson Cancer Center

ORCID

Career Start Year

1998

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37525555	Invasive Carcinoma With Skin Adnexal Trichilemmal Hair Follicular Differentiation Occurring in the Breast: A Case Report With Detailed Immunohistochemical and Molecular Analysis.	Int J Surg Pathol	2024
37573674	Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma.	Eur J Cancer	2023
37586834	Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma.	J Clin Pathol	2023
37744722	Isolated Flat Epithelial Atypia: Upgrade Outcomes After Multidisciplinary Review-Based Management Using Excision or Imaging Surveillance.	J Breast Imaging	2023
34319162	Axillary Nodal Metastases in Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma: Comparison of Node Detection and Morphology by Ultrasound.	AJR Am J Roentgenol	2022
35447141	Metastatic nonhematopoietic neoplasms to the breast: a study of 238 cases.	Hum Pathol	2022
35413381	TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma.	Hum Pathol	2022
35063444	Expression of TRPS1 in phyllodes tumor and sarcoma of the breast.	Hum Pathol	2022
34312396	Evaluation of multiple transcriptomic gene risk signatures in male breast cancer.	NPJ Breast Cancer	2021
33527629	MYC and NOTCH1-positive postradiation cutaneous angiosarcoma of the breast.	Breast J	2021
33577643	Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management.	Arch Pathol Lab Med	2021
34804623	Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Clinicopathologic Analysis with Evaluation of the E-Cadherin/<i>Î²</i>-Catenin Complex and Associated Genetic Alterations.	Case Rep Pathol	2021
32700044	Value Added Impact of Both Point-of-Care and Laboratory Lactic Acid Analysis When Emergently Evaluating Cancer Patients.	Oncol Ther	2020
31755777	Improving Patient Experience of Wait Times and Courtesy Through Electronic Sign-in and Notification in the Phlebotomy Clinic.	Arch Pathol Lab Med	2020
33218360	Sinonasal analogue HPV related breast multiphenotypic carcinoma, a report of a case with the first description in the breast.	Diagn Pathol	2020
32939920	Breast amyloidosis in a dormant plasma cell myeloma.	Breast J	2020
32700071	Carcinoma In Situ Involving Sclerosing Adenosis on Core Biopsy: Diagnostic Pearls to Aid the Practicing Clinician and Avoid Overtreatment.	Oncol Ther	2020
30072190	Imaging of Intracystic Papillary Carcinoma.	Curr Probl Diagn Radiol	2019
29092024	Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.	Ann Oncol	2018
29618460	A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer <i>In Situ</i>.	Cancer Prev Res (Phila)	2018
29512395	Fifteen-Year Journey to High Reliability in Pathology and Laboratory Medicine.	Am J Med Qual	2018
28843370	A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer.	Int J Radiat Oncol Biol Phys	2017
28199793	Pulmonary Mucinous Cystadenocarcinoma Presenting as Extensive Multifocal Cystic Lesions.	Am J Respir Crit Care Med	2017
25273328	Breast pathology second review identifies clinically significant discrepancies in over 10% of patients.	J Surg Oncol	2015
25631879	Adenomyoepithelioma of the breast with associated atypical lobular hyperplasia: a previously unrecognized association with management implications.	Ann Diagn Pathol	2015
24639339	Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting.	Cancer Med	2014
24695900	Second-opinion pathologic review is a patient safety mechanism that helps reduce error and decrease waste.	J Oncol Pract	2014
22899286	The effect of prolonged cold ischemia time on estrogen receptor immunohistochemistry in breast cancer.	Mod Pathol	2013
24283855	Inpatient preanalytic process improvements.	Arch Pathol Lab Med	2013
24119786	Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision.	Clin Breast Cancer	2013
22009292	Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer.	Cancer	2012
21334720	Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation.	Hum Pathol	2011
21631266	Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ.	Arch Pathol Lab Med	2011
21698015	Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue.	Biomed Opt Express	2011
20210524	Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy.	Cancer Invest	2010
21258518	High-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer: a pilot study.	Biomed Opt Express	2010
20519803	Wound complications from surgery in pregnancy-associated breast cancer (PABC).	Breast Dis	2010
20121597	Is it too soon to start reporting HER2 genetic heterogeneity?	Arch Pathol Lab Med	2010
19280264	Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation.	Ann Surg Oncol	2009
19362281	Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer.	Am J Surg	2009
19415952	Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases.	Arch Pathol Lab Med	2009
19172584	Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.	Cancer	2009
19064970	Ductal carcinoma in situ: state of the science and roadmap to advance the field.	J Clin Oncol	2009
19204903	The impact of pregnancy on breast cancer outcomes in women<or=35 years.	Cancer	2009
19197997	Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.	Cancer	2009
18373644	IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas.	Breast J	2008
19020230	Primary breast cancer in men: clinical, imaging, and pathologic findings in 57 patients.	AJR Am J Roentgenol	2008
18983463	Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion.	Histopathology	2008
17826054	Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast.	Am J Surg	2007
17927587	Loss of myoepithelium is variable in solid papillary carcinoma of the breast.	Histopathology	2007

1 - 50 of 94

Francisco Beca

Stanford University School of Medicine

Career Start Year 2008

Number of shared co-authors 1

Hannah Y Wen

Memorial Sloan Kettering Cancer Center

Career Start Year 2007

Number of shared co-authors 4

Leonard Da Silva

Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.

Career Start Year 2007

Number of shared co-authors 1

Nicola Fusco

IEO European Institute of Oncology IRCCS

Career Start Year 2002

Number of shared co-authors 3

Rita A Sakr

Universite Libre de Bruxelles

Career Start Year 2000

Number of shared co-authors 3

Paul Fr??neaux

Institut Curie

Career Start Year 1999

Number of shared co-authors 0

Jorge S Reis-Filho

Memorial Sloan-Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 13

Sarah L Blair

University of California

Career Start Year 1996

Number of shared co-authors 4

Amy C Degnim

Mayo Clinic

Career Start Year 1996

Number of shared co-authors 4

Elizabeth L Salisbury

Prince of Wales Hospital

Career Start Year 1995

Number of shared co-authors 0

Peter Bult

Radboud University Medical Center

Career Start Year 1994

Number of shared co-authors 3

Rosemary L Balleine

Westmead Institute for Medical Research, The University of Sydney

Career Start Year 1993

Number of shared co-authors 4

Wey L Leong

University Health Network

Career Start Year 1992

Number of shared co-authors 0

Paul J van Diest

University Medical Center Utrecht

Career Start Year 1989

Number of shared co-authors 16

Christina S Kong

Stanford University School of Medicine

Career Start Year 1988

Number of shared co-authors 1

Juan P Palazzo

Thomas Jefferson University Hospital

Career Start Year 1988

Number of shared co-authors 4

Christos Markopoulos

National and Kapodistrian University of Athens

Career Start Year 1987

Number of shared co-authors 6

Elizabeth Mallon

Queen Elizabeth University Hospital

Career Start Year 1986

Number of shared co-authors 5

Ossama Tawfik

University of Kansas

Career Start Year 1985

Number of shared co-authors 1

Bruce Youngson

University Health Network

Career Start Year 1985

Number of shared co-authors 0

Craig D Shriver

Walter Reed National Military Medical Center

Career Start Year 1985

Number of shared co-authors 4

Gary L Keeney

Mayo Clinic

Career Start Year 1984

Number of shared co-authors 2

David R McCready

University of Toronto, University Health Network

Career Start Year 1984

Number of shared co-authors 5

Rex C Bentley

Duke School of Medicine

Career Start Year 1984

Number of shared co-authors 1

Sunil R Lakhani

University of Queensland

Career Start Year 1983

Number of shared co-authors 13

Jos?? Palacios

Universidad de Alcala

Career Start Year 1983

Number of shared co-authors 2

Hans-Peter Sinn

Pathologisches Institut, Universitatsklinikum Heidelberg

Career Start Year 1981

Number of shared co-authors 4

Jahn M Nesland

The Norwegian Radium Hospital, Oslo University Hospital

Career Start Year 1980

Number of shared co-authors 0

Bernard T??tu

Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)

Career Start Year 1979

Number of shared co-authors 0

Jeffrey S Ross

Foundation Medicine

Career Start Year 1974

Number of shared co-authors 10

row(s) 1 - 30 of 30

Kelly K Hunt

The University of Texas MD Anderson Cancer Center

Co-authored papers 16

Funda Meric-Bernstam

University of Texas MD Anderson Cancer Center

Co-authored papers 13

Thomas A Buchholz

Co-authored papers 10

Gabriel N Hortobagyi

The University of Texas MD Anderson Cancer Center

Co-authored papers 9

Maria J Merino

National Cancer Institute, National Institutes of Health

Co-authored papers 7

Gary J Whitman

Co-authored papers 6

Wei Yang

Co-authored papers 4

Sharon H Giordano

The University of Texas MD Anderson Cancer Center

Co-authored papers 4

Peter J Dempsey

University of Colorado

Co-authored papers 4

Judy C Boughey

Mayo Clinic

Co-authored papers 3

Kim Benstead

Gloucestershire Hospitals NHS Foundation Trust

Co-authored papers 2

Fatima Cardoso

Champalimaud Clinical Center/Champalimaud Foundation

Co-authored papers 2

Jane Bayani

Ontario Institute for Cancer Research

Co-authored papers 2

John M S Bartlett

University of Edinburgh

Co-authored papers 2

Larissa A Korde

Clinical Investigations Branch, National Cancer Institute

Co-authored papers 2

Oliver B??gler

American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University

Co-authored papers 2

Lissandra Dal Lago

Institut Jules Bordet

Co-authored papers 2

Isabel T Rubio

Clinica Universidad de Navarra, Cancer Center Universidad de Navarra

Co-authored papers 2

Ingrid Hedenfalk

Lund University and Skane University Hospital

Co-authored papers 2

Paul H Duray

National Cancer Institute, National Institutes of Health